Trials / Completed
CompletedNCT02911545
Non-vitamin K Oral Anticoagulants in Cardioversion
Non-vitamin K Oral Anticoagulants in Cardioversion of Atrial Fibrillation. FinCV3
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (actual)
- Sponsor
- Helsinki University Central Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Non-vitamin K oral anticoagulants (NOAC) have been shown to be safe and effective alternatives to warfarin for stroke prevention in patients with nonvalvular AF (NVAF). There are yet limited real life data on outcomes following elective cardioversion in AF patients treated with NOACs. The aim of this study is to investigate the complications and the use of NOACs in AF patients undergoing cardioversion.
Conditions
Timeline
- Start date
- 2011-10-01
- Primary completion
- 2015-12-01
- Completion
- 2016-05-01
- First posted
- 2016-09-22
- Last updated
- 2016-09-22
Source: ClinicalTrials.gov record NCT02911545. Inclusion in this directory is not an endorsement.